Q2 FY2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: Calidi Biotherapeutics(CLDI) the EBIT is -4.15 M (+26.73%);the EPS is -2.94 (+90.75%).
Actual
YoY
Estimate
YoY
Vs estimate
YoY
EBIT
-0.00B26.73%
----
----
EPS
-2.937990.75%
----
----
Revenue
ActualEstimateUnit: USD
qf
EBIT
ActualEstimateUnit: USD
qf
Net income
ActualEstimateUnit: USD
qf
EPS
ActualEstimateUnit: USD
qf